DOI: 10.36347/sjams.2016.v04i05.032

Pages: 1600-1602

Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. The A1C test is a blood test that provides information about a person’s average levels of blood glucose, also called blood sugar, over the past 3 months. The Aim is to study roll of HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. The Study consists of 120 type 2 DM patients of 40-70 year age group along with age and sex matched healthy control. Fasting Blood samples were collected from all participants for measurement of Lipid profile, Blood sugar (FBS) and HbA1c. In case group, the mean concentration of Fasting blood glucose(mg/dl), S.Cholestrol (mg/dl), S.Triglyceride (mg/dl), S.HDL(mg/dl) and HbA1c(%) is 138.5±5.2, 265±10.5, 210.9±5.2, 38.6±6.3 and 10.6±1.0. Respectively while in control group it is 85.6±6, 156.9±8.5, 119.5±7.3, 44.5±3.2 and 5.2±0.5 respectively.TheHbA1C might be used as a reliable biomarker in the screening of dyslipidemia in diabetes type-2 patients because it showed positive correlation with TC,TG,VLDL,and LDL-C but negative correlation with HDL-C.